SPEAKERS

Elina Drakvik

Senior Lead at Finnish Innovation Fund SITRA

Elina Drakvik works as a Senior Lead at Sitra, the Finnish Innovation Fund, Well-being Solutions. She is part of the Coordination team of TEHDAS – Towards European Health Data Space Joint Action and TEHDAS2 project. Her job involves promoting the secondary use of health data in Finland and Europe and collaborating with international health ecosystems and organisations. She has over 10 years of experience in European cooperation in the field of health research, and she has expertise in establishing the European Health Data Space for secondary use. Elina’s professional interests include societal impact and systemic change towards sustainable development, where health and well-being are understood broadly. In addition to her position at Sitra, Elina is affiliated with the Faculty of Medicine at the University of Helsinki.

Lise-Lotte Lääne
Regional head of the Life Sciences & Healthcare sector group at the law office Sorainen

Daily, Lise-Lotte advises global pharmaceutical manufacturers, medical device manufacturers, health tech startups, and healthcare providers on a wide variety of matters in the field. With more than 10 years of experience as a lawyer, Lise-Lotte’s main focus areas are regulatory (including medical device-related issues), data protection, and intellectual property. More and more, legal advice in the sector also involves providing legal advice on the EU AI Act. Law office Sorainen is the biggest regional law firm in the Baltics having offices in all three Baltic countries, and providing pan-Baltic assistance to clients in all legal areas.

Sander Pajusalu
Head of the Genetics and Personalized Medicine Clinic at the Tartu University Hospital and an associate professor of clinical genetics at the University of Tartu.

He graduated from Tartu University as an MD in 2013 and completed his PhD studies as well as the medical genetics residency program at the same university in 2017. From 2018 to 2020, he was a postdoctoral associate and fellow at the Yale University School of Medicine, where he worked with Professor Monkol Lek. Sander Pajusalu has been involved in implementing novel diagnostic methods like next-generation sequencing into routine healthcare in Estonia. He has co-authored more than 50 peer-reviewed research publications on different topics in the field of rare genetic disorders. He is a member of the Estonian, European and American Societies of Human Genetics. He is a founding member and the first president of the Estonian Society of Personalized Medicine, and a board member of the Estonian Medical Genetics Society.

Pilvi Ilves
Head of the Radiology Clinic at the Tartu University Hospital and an associate professor at the University of Tartu.

She graduated from the University of Tartu after an internship in 1987 as an anesthesiologist and defended her doctoral thesis in 1999. After completing her radiology residency program at the University of Tartu in 2003 she has been active as a radiology lecturer there. She has worked as a radiologist in various Swedish university hospitals from 2004 to 2009. Since 2009 she has been elected as the head of the radiology clinic of the University of Tartu and since 2010 as the head of the radiology clinic of the Tartu University Hospital. Over the years, the radiology clinic has grown significantly both in terms of the number of employees and the amount of equipment. Under her leadership, several innovative methods have been introduced in the Radiology Clinic of the University of Tartu, including AI solutions, to cope with the growing volume of work in radiology. She has co-authored more than 200 peer-reviewed research publications.

Vincent Vercamer
Project Director at the Digital Health Delegation (DNS) of the French Ministry of Health and Prevention

Vincent Vercamer is a market access expert of digital medical devices, and in particular, the PECAN Fast track which aims to reimburse innovative DTx or new telemonitoring activities. He also coordinates the G_NIUS platform, which is designed to save time for digital health innovators in their go-to-market journey.